Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone for Breast Milk Production in Mothers of Preterm Infants
NCT01512225Phase 2
Key facts
- Status
- Completed
- Start
- May 2012
- Primary completion
- Oct 2015
- Countries
- 1
- Sponsor
- Sunnybrook Health Sciences Centre
- Modality
- Small Molecules
- Drugs
- domperidone
- Conditions
- lactation insufficiency
01
Overview
Phase 2, randomised, double-blind trial of domperidone in lactation insufficiency, sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Increase in Breast Milk Production. Started May 2012; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Mothers of preterm infants (<30 weeks) experiencing low milk supply 7-21 days postpartum, pumping at least 6 times daily, and without cardiac or gastrointestinal contraindications.
04
Endpoints
Primary
Increase in Breast Milk Production
Beyond the preview
Go deeper on NCT01512225.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01512225.